Amedisys Inc  

(Public, NASDAQ:AMED)   Watch this stock  
Find more results for AMED
29.06
+0.06 (0.21%)
Jan 28 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 28.86 - 30.02
52 week 12.86 - 30.48
Open 29.16
Vol / Avg. 0.00/240,079.00
Mkt cap 969.70M
P/E     -
Div/yield     -
EPS -0.16
Shares 33.38M
Beta 0.87
Inst. own 98%
Mar 2, 2015
Q4 2014 Amedisys Inc Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Jan 14, 2015
Amedisys Inc at JPMorgan Healthcare Conference
Dec 11, 2014
Amedisys Inc at Oppenheimer Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 2.86% -7.58%
Operating margin 5.41% -12.40%
EBITD margin - 3.35%
Return on average assets 4.95% -13.00%
Return on average equity 8.96% -22.58%
Employees 14,300 -
CDP Score - -

Address

5959 S SHERWOOD FOREST BLVD
BATON ROUGE, LA 70816
United States - Map
+1-225-2922031 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Amedisys, Inc. (Amedisys) is a health care at home company. The Company delivers personalized home health and hospice care to approximately 360,000 patients each year. It is focused on delivering patient-centered care, whether that is home-based recovery and rehabilitation after an operation or injury, care focused to manage a chronic disease, palliative care for those with a terminal illness, or hospice care at the end of life. The Company owns and operates approximately 367 Medicare-certified home health care centers, 92 Medicare-certified hospice care centers and one hospice inpatient unit. The Company operates in two segments: home health and hospice. Home health segment delivers a range of services in the homes of individuals who may be recovering from an illness, injury or surgical procedure. Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness.

Officers and directors

Paul B. Kusserow President, Chief Executive Officer, Director
Age: 53
Bio & Compensation  - Reuters
Ronald A. LaBorde Vice Chairman of the Board
Age: 57
Bio & Compensation  - Reuters
Dale E. Redman Interim Chief Financial Officer
Age: 66
Bio & Compensation  - Reuters
Jeffrey D. Jeter Chief Compliance Officer
Age: 42
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
David R. Bucey General Counsel, Corporate Secretary
Age: 56
Bio & Compensation  - Reuters
Michael O. Fleming M.D. Chief Medical Officer
Age: 63
Bio & Compensation  - Reuters
Donald A. Washburn Non-Executive Chairman of the Board
Age: 69
Bio & Compensation  - Reuters
Nathaniel M. Zilkha Director
Age: 39
Bio & Compensation  - Reuters
Linda J. Hall Independent Director
Age: 65
Bio & Compensation  - Reuters
Jake L. Netterville Independent Director
Age: 76
Bio & Compensation  - Reuters